Ubs Group Ag Hookipa Pharma Inc. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HOOK
# of Institutions
43Shares Held
23.7MCall Options Held
98.5KPut Options Held
46.6K-
Eco R1 Capital, LLC San Francisco, CA5.72MShares$24.2 Million0.12% of portfolio
-
Artal Group S.A. Luxembourg, N45.67MShares$24 Million0.21% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.52MShares$23.4 Million2.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$8.99 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.06MShares$4.51 Million0.04% of portfolio
About HOOKIPA Pharma Inc.
- Ticker HOOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,654,500
- Market Cap $219M
- Description
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...